Literature DB >> 20584520

Persistent depressive symptoms and cognitive function in late midlife: the Whitehall II study.

Archana Singh-Manoux1, Tasnime N Akbaraly, Michael Marmot, Maria Melchior, Joël Ankri, Séverine Sabia, Jane E Ferrie.   

Abstract

OBJECTIVE: Depression has been widely linked to poor cognition and dementia in the elderly. However, comorbidity at older ages does not allow an assessment of the role of mental health as a risk factor for cognitive outcomes. We examined the association between depressive symptoms, measured 6 times over an 18-year period, and cognitive deficits in late midlife.
METHOD: Of the 10,308 participants in the Whitehall II study, 4,271 men and women (aged 35-55 years at baseline) were followed up for 18 years, during which depressive symptoms were assessed 6 times using the General Health Questionnaire depression subscale. The follow-up was from 1985-1988 to 2002-2004. Cognition was assessed at the most recent wave (2002-2004, mean age 61 years, range 50-74 years) using 6 tests: memory, reasoning, vocabulary, 2 tests of verbal fluency, and the MMSE (Mini Mental State Examination). Cognitive deficit was defined as MMSE score <28 and performance in the worst sex-specific quintile for the other tests.
RESULTS: History of depressive symptoms, once or more in the 6 times assessed, had a weak association with some of the cognitive tests. However, in analysis adjusted for sociodemographic variables, diabetes, coronary heart disease, hypertension, stroke, and antidepressant use, persistent depressive symptoms (4-6 times) were associated with cognitive deficits on all tests: memory (OR=1.91; 95% CI, 1.36-2.67), reasoning (OR=1.60; 95% CI, 1.15-2.20), vocabulary (OR=1.75; 95% CI, 1.27-2.41), phonemic fluency (OR=1.40; 95% CI, 1.00-1.94), semantic fluency (OR=1.68; 95% CI, 1.20-2.35), and the MMSE (OR=1.76; 95% CI, 1.25-2.50).
CONCLUSIONS: Our data show that depressive episodes tend to persist in some individuals, and these individuals are at a greater risk of cognitive deficits in late midlife. © Copyright 2010 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20584520      PMCID: PMC3112169          DOI: 10.4088/JCP.09m05349gry

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  47 in total

1.  The temporal relationship between depressive symptoms and dementia: a community-based prospective study.

Authors:  P Chen; M Ganguli; B H Mulsant; S T DeKosky
Journal:  Arch Gen Psychiatry       Date:  1999-03

2.  Depressive symptomatology and incident cognitive decline in an elderly community sample.

Authors:  S S Bassuk; L F Berkman; D Wypij
Journal:  Arch Gen Psychiatry       Date:  1998-12

3.  A scaled version of the General Health Questionnaire.

Authors:  D P Goldberg; V F Hillier
Journal:  Psychol Med       Date:  1979-02       Impact factor: 7.723

4.  Is depression in elderly people followed by dementia? A retrospective cohort study based in general practice.

Authors:  F Buntinx; A Kester; J Bergers; J A Knottnerus
Journal:  Age Ageing       Date:  1996-05       Impact factor: 10.668

5.  A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease.

Authors:  D C Steffens; B L Plassman; M J Helms; K A Welsh-Bohmer; A M Saunders; J C Breitner
Journal:  Biol Psychiatry       Date:  1997-04-15       Impact factor: 13.382

6.  Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease.

Authors:  R Migliorelli; A Tesón; L Sabe; M Petracchi; R Leiguarda; S E Starkstein
Journal:  Am J Psychiatry       Date:  1995-01       Impact factor: 18.112

7.  Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

Authors:  D P Devanand; M Sano; M X Tang; S Taylor; B J Gurland; D Wilder; Y Stern; R Mayeux
Journal:  Arch Gen Psychiatry       Date:  1996-02

8.  Unique and interactive effects of depression, age, socioeconomic advantage, and gender on cognitive performance of normal healthy older people.

Authors:  P Rabbitt; C Donlan; P Watson; L McInnes; N Bent
Journal:  Psychol Aging       Date:  1995-09

9.  Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group.

Authors:  A F Jorm; C M van Duijn; V Chandra; L Fratiglioni; A B Graves; A Heyman; E Kokmen; K Kondo; J A Mortimer; W A Rocca
Journal:  Int J Epidemiol       Date:  1991       Impact factor: 7.196

10.  Work characteristics and psychiatric disorder in civil servants in London.

Authors:  S A Stansfeld; F M North; I White; M G Marmot
Journal:  J Epidemiol Community Health       Date:  1995-02       Impact factor: 3.710

View more
  21 in total

1.  A longitudinal study of differences in late- and early-onset geriatric depression: depressive symptoms and psychosocial, cognitive, and neurological functioning.

Authors:  Natalie Sachs-Ericsson; Elizabeth Corsentino; Jerad Moxley; Jennifer L Hames; Nicole C Rushing; Kathryn Sawyer; Thomas Joiner; Edward A Selby; Steven Zarit; Ian H Gotlib; David C Steffens
Journal:  Aging Ment Health       Date:  2012-08-30       Impact factor: 3.658

2.  Mood is a key determinant of cognitive performance in community-dwelling older adults: a cross-sectional analysis.

Authors:  Nadine Correia Santos; Patrício Soares Costa; Pedro Cunha; Jorge Cotter; Adriana Sampaio; Joseph Zihl; Osborne F X Almeida; João J Cerqueira; Joana Almeida Palha; Nuno Sousa
Journal:  Age (Dordr)       Date:  2012-10-06

3.  Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens.

Authors:  Tonita E Wroolie; Heather A Kenna; Katherine E Williams; Bevin N Powers; Megan Holcomb; Anna Khaylis; Natalie L Rasgon
Journal:  Am J Geriatr Psychiatry       Date:  2011-09       Impact factor: 4.105

4.  Change in sleep duration and cognitive function: findings from the Whitehall II Study.

Authors:  Jane E Ferrie; Martin J Shipley; Tasnime N Akbaraly; Michael G Marmot; Mika Kivimäki; Archana Singh-Manoux
Journal:  Sleep       Date:  2011-05-01       Impact factor: 5.849

5.  Long working hours and symptoms of anxiety and depression: a 5-year follow-up of the Whitehall II study.

Authors:  M Virtanen; J E Ferrie; A Singh-Manoux; M J Shipley; S A Stansfeld; M G Marmot; K Ahola; J Vahtera; M Kivimäki
Journal:  Psychol Med       Date:  2011-02-18       Impact factor: 7.723

6.  Depressive Symptoms and Longitudinal Changes in Cognition: Women's Health Initiative Study of Cognitive Aging.

Authors:  Joseph S Goveas; Mark A Espeland; Patricia E Hogan; Hilary A Tindle; Regina A Shih; Jane M Kotchen; Jennifer G Robinson; Deborah E Barnes; Susan M Resnick
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-02-28       Impact factor: 2.680

7.  Estimating the Prevalence of Serious Mental Illness and Dementia Diagnoses Among Medicare Beneficiaries in the Health and Retirement Study.

Authors:  Maria Teresa Brown; Douglas A Wolf
Journal:  Res Aging       Date:  2017-08-31

8.  Patterns of late-life depressive symptoms and subsequent declines in cognitive domains.

Authors:  J Cai Gillis; Shun-Chiao Chang; Elizabeth E Devore; Bernard A Rosner; Francine Grodstein; Olivia I Okereke
Journal:  Int J Geriatr Psychiatry       Date:  2016-11-07       Impact factor: 3.485

9.  Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial.

Authors:  Mark D Sullivan; Wayne J Katon; Laura C Lovato; Michael E Miller; Anne M Murray; Karen R Horowitz; R Nick Bryan; Hertzel C Gerstein; Santica Marcovina; Basil E Akpunonu; Janice Johnson; Jean Francois Yale; Jeff Williamson; Lenore J Launer
Journal:  JAMA Psychiatry       Date:  2013-10       Impact factor: 21.596

10.  Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort study.

Authors:  Sara Kaffashian; Aline Dugravot; Eric J Brunner; Séverine Sabia; Joël Ankri; Mika Kivimäki; Archana Singh-Manoux
Journal:  Alzheimers Dement       Date:  2012-11-28       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.